Citations

Clear

13603 citation(s) found for "_, _".

AKIRA: Deep learning tool for image standardization, implant detection and arthritis grading to establish a radiographic registry in patients with anterior cruciate ligament injuries
Lu, Yining , Yang, Linjun , Grove, Austin F , Kaji, Ellie, Pareek, Ayoosh , Levy, Bruce A. , Mulford, Kellen, Grove, Austin , Kaji, Ellie , Lu, Yining , Yang, Linjun, Mulford, Kellen L. , Wyles, Cody C. , Camp, Christopher L. , Krych, Aaron J.

Mayo Clinic

Knee Surgery, Sports Traumatology, Arthroscopy | February 11, 2025 | Volume: 33 | Issue: 11 | Pages: 3772-3780

10.1002/ksa.12618 | PMID 39925136 Get It

Abstract Purpose Developing large‐scale, standardized radiographic registries for anterior cruciate ligament (ACL) injuries with artificial intelligence (AI) tools can enhance personalized orthopaedics. We propose deploying Artificial Intelligence for Knee Imaging Registration and Analysis (AKIRA), a trio of deep learning (DL) algorithms, to automatically classify and annotate radiographs. We hypothesize that algorithms can efficiently organize radiographs based on laterality, projection, identify implants and classify osteoarthritis (OA) grade. Methods A collection of 20,836 knee radiographs from all time points of treatment (mean orthopaedic follow‐up 70.7 months; interquartile range [IQR]: 6.8–172 months) were aggregated from 1628 ACL‐injured patients (median age 26 years [IQR: 19–42], 57% male). Three DL algorithms (EfficientNet, YOLO [You Only Look Once] and Residual Network) were employed. Radiograph laterality and projection (anterior‐posterior [AP], lateral, sunrise, posterior‐anterior, hip–knee–ankle and Camp‐Coventry intercondylar [notch]) were labelled by a DL model. Manually provided labels of metal fixation implants were used to develop a DL object detection algorithm. The degree of OA, both as measured by specific Kellgren–Lawrence (KL) grades, as well as based on a binarized label of OA (defined as KL Grade ≥2), on standing AP radiographs were classified using a DL algorithm. Individual model performances were evaluated on a subset of images prior to the deployment of AKIRA to registry construction using all ACL radiographs. Results The classification algorithms showed excellent performance in classifying radiographic laterality (F1 score: 0.962–0.975) and projection (F1 score: 0.941–1.0). The object detection algorithm achieved high precision–recall (area under the precision‐recall curve: 0.695–0.992) for identifying various metal fixations. The KL classifier reached concordances of 0.39–0.40, improving to 0.81–0.82 for binary OA labels. Sequential deployment of AKIRA following internal validation processed and labelled all 20,836 images with the appropriate views, implants, and the presence of OA within 88 min. Conclusion AKIRA effectively automated the classification and object detection in a large radiograph cohort of ACL injuries, creating an AI‐enabled radiographic registry with comprehensive details on laterality, projection, implants and OA. Study Design Cross‐sectional study. Level of Evidence Level IV.
Spectral performance for iodine quantification of a dual‐source, dual‐kV photon counting detector CT
Winfree, Tim N., Treb, Kevin , Leng, Shuai, Winfree, Tim, McCollough, Cynthia, Treb, Kevin , McCollough, Cynthia H. , Leng, Shuai

Mayo Clinic

Medical Physics | February 10, 2025 | Volume: 52 | Issue: 5 | Pages: 2824-2831

10.1002/mp.17679 | PMID 39930273 Get It

Abstract Background Multi‐energy CT (MECT) enables quantification of material concentrations by measuring linear attenuation coefficient line integrals with multiple x‐ray spectra. Photon counting detector (PCD)‐CT utilizes a detector‐based approach for MECT that can suffer from substantial spectral overlap, resulting in amplified material quantification noise. Dual‐source dual‐kV approaches for MECT are currently utilized in some energy‐integrating detector (EID)‐CT systems and can potentially be utilized with PCD‐CT for improved spectral separation. Purpose To evaluate the iodine quantification performance of a novel dual‐source (DS)‐PCD‐CT scan mode and compare to single‐source (SS)‐PCD‐CT and DS‐EID‐CT. Materials and Methods A 30 cm × 40 cm solid water phantom with four iodine inserts (2, 5, 10, and 15 mg/mL) was scanned with the three spectral modalities: SS‐PCD‐CT with two energy thresholds, DS‐PCD‐CT (90/Sn150 kV), and DS‐EID‐CT (90/Sn150 kV). For each modality, full‐dose (12 mGy) and half‐dose scans were acquired, and images were reconstructed with filtered back‐projection using a quantitative (Qr40) kernel. When scanning in a DS configuration, the total radiation dose budget is split between two detectors, increasing the strength of a signal‐dependent filter compared to a SS acquisition. To account for this effect, the modulation transfer function (MTF) for each modality was measured from a 0.05 mm tungsten wire. A linear spatial filter was applied to the SS images to match their MTF to that of the DS images. The resulting high‐ and low‐energy images were input into an image‐domain least squares material decomposition algorithm with iodine and water as the two basis materials. Iodine quantification accuracy and noise measured from the iodine basis images were used as figures of merit, and t‐tests used to compare between modalities. Results The 10% MTF cutoffs were 0.56, 0.57, 0.60, and 0.57 lp/mm for DS‐EID‐CT, DS‐PCD‐CT, SS‐PCD‐CT, and SS‐PCD‐CT after MTF‐matching, respectively, with the SS‐PCD‐CT MTF cutoff dropping to 0.58 lp/mm at half‐dose. Without accounting for the signal‐dependent filter by matching the MTFs, the noise in iodine material basis images from SS‐PCD‐CT was 10% higher than that of DS‐EID‐CT. After matching the MTFs, the noise in the SS‐PCD‐CT iodine image was 9%–22% lower than that of the DS‐EID‐CT. The lowest iodine image noise was from the DS‐PCD‐CT, which was 39%–41% lower than the DS‐EID‐CT. The DS‐PCD‐CT noise magnitude was significantly different from the other modalities. Mean iodine quantification accuracy across all measured concentrations was within 5% for all modalities at full dose, but was only below 5% for the DS‐PCD‐CT at half‐dose. Conclusions SS‐PCD‐CT with two energy thresholds outperformed DS‐EID‐CT in terms of image noise in iodine basis images when spatial resolution was matched. DS‐PCD‐CT gave the lowest noise due to the combination of PCD technology and improved spectral separation from the different x‐ray spectra.
Experts Achieve Consensus on a Majority of Statements Regarding Ethics, Transparency, Regulation, and Best Practices for the Use of Orthobiologics
Gilat, Ron , Muth, Sarah A. , Hurley, Eoghan T. , Yazdi, Allen A. , Franzia, Chloe H, Shapiro, Shane A. , Cole, Brian J. , Shapiro, Shane , Franzia, Chloe H., Rodeo, Scott A. , Frank, Rachel M , Kon, Elizaveta

Mayo Clinic

Arthroscopy | February 10, 2025 | Volume: 41 | Issue: 9 | Pages: 3611-3621

10.1016/j.arthro.2025.01.062 | PMID 39938667 Get It

Purpose To establish consensus statements via a modified Delphi process about ethics, transparency, regulation, and best practices for the use of orthobiologics in clinical practice for musculoskeletal pathology. Methods A consensus process on the regulation of orthobiologics at the provider level was conducted using a modified Delphi technique. Twenty orthopaedic surgeons, sports medicine physicians, or basic scientists participated. Each participant was a Biologic Association member organization representative and asked to participate because of their active interest in the field of orthobiologics. Levels of consensus were delineated according to the number of votes for each statement: no consensus, <80%; consensus, 80% to 89%; strong consensus, 90% to 99%; unanimous, 100%. Results The 26 consensus statements on orthobiologics resulted in 14 achieving unanimous consensus, 8 achieving strong consensus, 3 achieving consensus, and 1 did not achieve consensus. Overall, 85% of the statements reached either a unanimous or strong consensus. Of the statements regarding communication and transparency, 9 reached unanimous consensus, including information to convey and helpful tools to describe current orthobiologics, persistent misinformation, use of the word “stem cells,” “off‐label” use, and problems with the present regulatory environment. Five statements discussing the regulation of novel orthobiologics achieved unanimous consensus. These statements highlighted research regulation, safety, and suggested improvements to regulatory issues. The statement that did not achieve any consensus was on the regulatory processes that should be in place by an institution providing novel orthobiologic treatments. No statement reached a unanimous agreement on cost or ethical considerations. Conclusions This study successfully identified key consensus statements emphasizing the importance of ethics, transparency, and regulation in the use of orthobiologics, with 85% of statements reaching unanimous or strong consensus. These findings underscore the need for standardized communication, improved regulatory frameworks, and enhanced safety measures while highlighting persistent challenges in addressing cost and ethical considerations. Level of Evidence Level V, expert opinion.
Aptamer-directed, nanovesicle-mediated targeting of undruggable molecules in preclinical cholangiocarcinoma models
Yu, Mincheng, Sample, Jack W. , Takaichi, Shohei , Watkins, Ryan , Werneburg, Nathan W., Carlson, Danielle M. , Cai, Meina , Ozmert, Enis H., Yang, Ju Dong , Smoot, Rory L. , Yan, Irene K. , Tomlinson, Jennifer L. , Loeuillard, Emilien J, Watkins, Ryan D, Kuipers, Hendrien , Yang, Jinchun, Smoot, Rory L , Sample, Jack W , Loeuillard, Emilien , Abdelrahman, Amro M. , Carlson, Danielle Marie , Kimball, Brooke , Yang, Ju Dong , Ilyas, Sumera I. , Gores, Gregory J. , Patel, Tushar

Mayo Clinic

Hepatology | February 10, 2025 | Volume: 82 | Issue: 5 | Pages: 1090-1111

10.1097/hep.0000000000001256 | PMID 39928593 Get It

Background and Aims: Cholangiocarcinoma (CCA) is an aggressive malignancy arising from the biliary epithelium with limited therapeutic options and poor long-term survival rates. To address the limitations of CCA treatment, we investigated cell-targeted nanovesicles as a delivery platform for transcriptome-targeting therapeutics. Approach and Results: Milk-derived nanovesicles were loaded with short interfering RNAs targeting Yes-associated protein (YAP), the downstream effector of the Hippo pathway; LCK, an upstream regulator of YAP; and tafazzin, a protein critical for the integrity of the inner mitochondrial membrane. These transcriptome-targeting nanovesicles were decorated with a lipid-coupled RNA aptamer to epithelial cell adhesion molecule, including a tracking fluorophore. In vitro studies were conducted using multiple CCA cell lines. In vivo studies were performed using C57BL/6 and non-obese diabetic/severe combined immunodeficient mice to evaluate delivery and efficacy in both an immunocompetent syngeneic murine and a patient-derived xenograft model. We demonstrated that transcriptome-targeting nanovesicles were selectively taken up by liver tumor cells, which was augmented by the incorporation of a targeting aptamer, and that milk-derived nanovesicles loaded with short interfering RNA effectively downregulated target gene expression, both in vitro and in vivo. Downstream effects of target gene inhibition were observed, including downregulation of YAP-TEAD target genes and an increase in reactive oxygen species production at the mitochondrial level. Administration of transcriptome-targeting nanovesicles targeting YAP, LCK, and tafazzin inhibited CCA growth and further synergized with chemotherapy in 2 preclinical CCA models. Conclusions: Herein, we show that aptamer-directed, nanovesicle-mediated targeting of YAP, LCK, and tafazzin potentiates chemosensitivity in 2 CCA models when delivered using aptamer-guided milk-derived nanovesicles.
A237 INCIDENCE, RISK FACTORS, AND OUTCOMES OF POST-ERCP CHOLANGITIS: AN INTERNATIONAL MULTICENTER PROSPECTIVE STUDY
Gupta, M, Fazal, Muhammad Ali, Hammal, Jessica , Ficaccio, Sara, Forbes, Nauzer , Khan, Rishad

Mayo Clinic

Journal of the Canadian Association of Gastroenterology | February 10, 2025 | Volume: 8 | Issue: Supplement_1 | Pages: i98-i98

10.1093/jcag/gwae059.237 Get It

Abstract Background Cholangitis is a well-described adverse event (AE) following endoscopic retrograde cholangiopancreatography (ERCP) that is associated with significant morbidity and mortality. Despite this, contemporary characterization of this AE using high-quality prospective data is incomplete. Aims In this study we describe post-ERCP cholangitis incidence, risk factors, and outcomes in a large, international multicenter population of patients undergoing ERCP. Methods We analyzed prospective data from nine centers in Canada, USA, and Europe between 2018-2024 with 30-day follow-up. The primary outcome was post-ERCP cholangitis, defined as (1) temperature &lt;36.0°C or &gt;38.0°C or white blood cells &lt;4 x109/L or &gt;10x109/L, (2) accompanying rise in bilirubin or transaminases to &gt;1.5 times the upper limit of normal or any increase compared to pre-procedure, and (3) emergency department visit or hospital admission and/or prolongation of existing admission. Multivariable logistic regression was performed to identify risk factors, with results presented as odds ratios (OR) with associated 95% confidence intervals. Outcomes following cholangitis were also described. Results Post-ERCP cholangitis occurred following 134 (1.7%) of 8,119 ERCPs (mean onset of symptoms 2.0 days). Repeat ERCP was required in 53.7% of these cases. Mortality attributed to cholangitis occurred in 8.2% of incident cases. Male sex (OR 1.48, 1.02-2.19), longer procedural time (OR 1.01, 1.00-1.02 per additional minute) and presence of a biliary stricture (OR 3.24, 1.98-5.30) were all independent risk factors for post-ERCP cholangitis, while placement of a biliary stent (OR 0.59, 0.36-0.95), and biliary sphincterotomy (OR 0.59 0.39-0.87) were both protective against post-ERCP cholangitis. Conclusions Post-ERCP cholangitis is common and associated with high mortality rates. Adequate pre-procedural counseling and early recognition is advised, especially in patients at increased risk. Funding Agencies None
Intraoperative Monitoring of Cranial Nerves III, IV, and VI: A Scoping Review
Knapp, Justin, Hiredesai, Annika, Ebbert, Landon, Pachon, Maria, Ghoche, Maged T. , Meyer, Jenna , Bendok, Bernard R. , Ebbert, Landon E. , Knapp, Justin, Hiredesai, Annika N.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 7, 2025 | Volume: 86 | Issue: No issue available | Pages: No page available

10.1055/s-0045-1803862 Get It

Assessing the Prognostic Value of Upfront Neck Disease in Olfactory Neuroblastoma: A Multicenter, Matched Cohort Study
Fung, Nicholas , Patel, Shivam , Champagne, Pierre‐Olivier , Fernandez‐Miranda, Juan C. , Gardner, Paul , Patel, Chirag , Celda, María Peris, Sanusi, Olabisi , Snyderman, Carl, Thorp, Brian D. , Zenonos, Georgios A. , Zwagerman, Nathan T. , Fung, Nicholas, Almeida, João Paulo , Hwang, Peter H. , Nayak, Jayakar V. , Patel, Zara M. , Pinheiro‐Neto, Carlos , Gompel, Jamie J. Van , Geltzeiler, Mathew , Choby, Garret , Wang, Eric W

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 7, 2025 | Volume: 86 | Issue: No issue available | Pages: No page available

10.1055/s-0045-1803566 Get It

Endonasal Anterior C1 Arch Removal, Odontoidectomy, and Inferior Clivusectomy for Cervicomedullary Stenosis
Llano, Juan Pablo Navarro Garcia de, Guevera, Maria, Sánchez-Garavito, Jesús E. , Ravindran, Krishnan , Donaldson, Angela M. , Buchanan, Ian A. , Chaichana, Kaisorn L. , Almeida, João Paulo

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 7, 2025 | Volume: 86 | Issue: No issue available | Pages: No page available

10.1055/s-0045-1803461 Get It

Highlighting the Iconographic Value in Microneurosurgery, Part 1: The Superficial and Deep Intracranial Venous System
Peris-Celda, Maria, Torregrossa, Fábio , Piazza, Amedeo , Lanzino, Giuseppe , Peris‐Celda, Maria

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 7, 2025 | Volume: 86 | Issue: No issue available | Pages: No page available

10.1055/s-0045-1803162 Get It

Endoscopic Endonasal Pituitary Transposition Followed by Posterior Clinoidectomy to Access the Retrosellar and Retroinfundiblar Space: A Comparison of Endocrinological Outcomes between Extradural, Interdural, and Intradural Techniques
Pachón-Londoño, María José , Olson, Vita A. , Ghoche, Maged T. , Bcharah, Estefana , Patra, Devi P. , Bathini, Abhijith , Moussalem, Charbel K. , Bendok, Bernard R.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 7, 2025 | Volume: 86 | Issue: No issue available | Pages: No page available

10.1055/s-0045-1803137 Get It